Skip to main content

Viable SARS-CoV-2 in various specimens from COVID-19 patients.

Jeong HW, Kim SM, Kim HS, Kim YI, Kim JH, Cho JY, Kim SH, Kang H, Kim SG, Park SJ, Kim EH, Choi YK

Publication: Clin Microbiol Infect (2020) • Vol 26 • Page 1520-1524PMID: 32711057View on PubMed

Purpose

This paper compared viral loads of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in matched naso/oropharyngeal swab, saliva, urine, and fecal specimens collected from four symptom-free recovering COVID-19 patients and one COVID-19 patient in critical condition.

 

Conclusion

SARS-CoV-2 RNA was detected using real-time qRT-PCR in all specimens collected. In specimens from the four symptom-free recovering patients, viral RNA loads were comparable to or higher in the urine and feces specimens and lower in saliva specimens than that of the matched naso/oropharyngeal swab. For the patient in critical condition, the viral load was lower in the urine specimen, comparable in saliva, but significantly higher in the fecal specimen compared to the matched naso/oropharyngeal swab.

Studies (1)

Purpose

This study compared viral loads of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in matched naso/oropharyngeal swab, saliva, urine, and fecal specimens collected from four symptom-free recovering COVID-19 patients and one COVID-19 patient in critical condition. Specimens were collected from five hospitalized patients (method of diagnosis not provided; median age=63 y; 3 males, 2 females). Four patients were symptom-free at the time of specimen collection (one had a mild clinical course without pneumonia and three were categorized as severe cases, day 8-30 of illness) and one patient was in critical condition with respiratory failure and septic shock (day 15 of illness; specimen collection, processing, preservation, and storage details not provided). Viral RNA was extracted using the QIAamp Viral RNA Mini Kit and cDNAs were generated by reverse transcription using QuantiTect Reverse Transcription. The SARS-CoV-2, S region was detected by real-time qRT-PCR and the number of viral RNA copies was calculated as log10 copies/mL.

 

Summary of Findings

SARS-CoV-2 RNA was detected by real-time qRT-PCR in all specimens collected. Of the four symptom-free patients, viral RNA loads were comparable to or higher in the urine and feces specimens (range from 1.08 ± 0.16 to 2.09 ± 0.85 log10 copies/mL) and lower in saliva specimens (range from 0.96 ± 0.31 to 1.65 ± 0.46 log10 copies/mL) than that of the matched naso/oropharyngeal swab (range from 1.18 ± 0.12 to 1.43 ± 0.42 log10 copies/mL). The viral load in specimens collected from the patient in critical condition was lower in urine (0.59 ± 0.35 log10 copies/mL), comparable in saliva (1.44 ± 0.40 versus 1.15 log10 copies/mL) and significantly higher in the fecal specimen (2.18 ± 0.11 log10 copies/mL) relative to the naso/oropharyngeal swab specimen (1.15 ± 0.03 log10 copies/mL).

  • Biospecimens

    CellNasopharynx
    CellOral Cavity
    FluidFeces
    FluidSaliva
    FluidUrine
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Pneumonia/Respiratory Infection
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Critical condition
    Free of clinical symptoms
    Biospecimen AcquisitionBiospecimen location
    feces
    naso/oropharyngeal swab
    saliva
    urine
    Real-time qRT-PCR SpecificTargeted nucleic acid
    SARS-CoV-2, S region